Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lee A O'Brien

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Frontiers in Bioscience : a Journal and Virtual Library|September 9, 2005
Activated protein C and sepsisLee A O'Brien, Akanksha Gupta, Brian W Grinnell
Journal of Chemical Information and Computer Sciences|November 25, 2003
Spline-fitting with a genetic algorithm: a method for developing classification structure-activity relationshipsJeffrey J Sutherland, Lee A O'Brien, Donald F Weaver
Journal of Medicinal Chemistry|October 16, 2004
A comparison of methods for modeling quantitative structure-activity relationshipsJeffrey J Sutherland, Lee A O'Brien, Donald F Weaver
Journal of Medicinal Chemistry|July 9, 2004
Pruned receptor surface models and pharmacophores for three-dimensional database searchingJeffrey J Sutherland, Lee A O'Brien, Donald F Weaver
Journal of Molecular Modeling|August 24, 2004
Molecular modeling of the von Willebrand factor A2 Domain and the effects of associated type 2A von Willebrand disease mutationsJeffrey J Sutherland, Lee A O'Brien, David Lillicrap, et al.
Biochemistry|November 5, 2003
Glycosaminoglycans bind factor Xa in a Ca2+-dependent fashion and modulate its catalytic activityLee A O'Brien, Alan R Stafford, James C Fredenburgh, et al.
British Journal of Haematology|November 7, 2008
ADAMTS13 cleavage efficiency is altered by mutagenic and, to a lesser extent, polymorphic sequence changes in the A1 and A2 domains of von Willebrand factorCynthia M Pruss, Colleen R P Notley, Carol A Hegadorn, et al.
The Journal of Biological Chemistry|October 12, 2007
Negative regulation of inducible nitric-oxide synthase expression mediated through transforming growth factor-beta-dependent modulation of transcription factor TCF11David T Berg, Akanksha Gupta, Mark A Richardson, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 13, 2007
Activated protein C decreases tumor necrosis factor related apoptosis-inducing ligand by an EPCR- independent mechanism involving Egr-1/Erk-1/2 activationLee A O'Brien, Mark A Richardson, Sean F Mehrbod, et al.
Clinical and Experimental Rheumatology|January 9, 2013
The role of the FcGRIIIa polymorphism in modifying the association between treatment and outcome in patients with rheumatoid arthritis treated with rituximab versus TNF-α antagonist therapiesKhaled Sarsour, Jeffrey Greenberg, Joseph A Johnston, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Frontiers in Bioscience : a Journal and Virtual Library|September 9, 2005
Activated protein C and sepsisLee A O'Brien, Akanksha Gupta, Brian W Grinnell
Journal of Chemical Information and Computer Sciences|November 25, 2003
Spline-fitting with a genetic algorithm: a method for developing classification structure-activity relationshipsJeffrey J Sutherland, Lee A O'Brien, Donald F Weaver
Journal of Medicinal Chemistry|October 16, 2004
A comparison of methods for modeling quantitative structure-activity relationshipsJeffrey J Sutherland, Lee A O'Brien, Donald F Weaver
Journal of Medicinal Chemistry|July 9, 2004
Pruned receptor surface models and pharmacophores for three-dimensional database searchingJeffrey J Sutherland, Lee A O'Brien, Donald F Weaver
Journal of Molecular Modeling|August 24, 2004
Molecular modeling of the von Willebrand factor A2 Domain and the effects of associated type 2A von Willebrand disease mutationsJeffrey J Sutherland, Lee A O'Brien, David Lillicrap, et al.
Biochemistry|November 5, 2003
Glycosaminoglycans bind factor Xa in a Ca2+-dependent fashion and modulate its catalytic activityLee A O'Brien, Alan R Stafford, James C Fredenburgh, et al.
British Journal of Haematology|November 7, 2008
ADAMTS13 cleavage efficiency is altered by mutagenic and, to a lesser extent, polymorphic sequence changes in the A1 and A2 domains of von Willebrand factorCynthia M Pruss, Colleen R P Notley, Carol A Hegadorn, et al.
The Journal of Biological Chemistry|October 12, 2007
Negative regulation of inducible nitric-oxide synthase expression mediated through transforming growth factor-beta-dependent modulation of transcription factor TCF11David T Berg, Akanksha Gupta, Mark A Richardson, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 13, 2007
Activated protein C decreases tumor necrosis factor related apoptosis-inducing ligand by an EPCR- independent mechanism involving Egr-1/Erk-1/2 activationLee A O'Brien, Mark A Richardson, Sean F Mehrbod, et al.
Clinical and Experimental Rheumatology|January 9, 2013
The role of the FcGRIIIa polymorphism in modifying the association between treatment and outcome in patients with rheumatoid arthritis treated with rituximab versus TNF-α antagonist therapiesKhaled Sarsour, Jeffrey Greenberg, Joseph A Johnston, et al.
Pageof 2